Q2 2026 Holdings
Filed 2026-08-12 | 8 holdings | $162.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc.(GLUE) | Common Stock | 61225M102 | $77.0M | 3,180,780 | 47.3% |
| Century Therapeutics, Inc.(IPSC) | Common Stock | 15673T100 | $29.8M | 12,166,109 | 18.3% |
| Jade Biosciences, Inc.(JBIO) | Common Stock | 008064206 | $22.0M | 991,783 | 13.6% |
| Lenz Therapeutics, Inc.(LENZ) | Common Stock | 52635N103 | $15.1M | 2,656,888 | 9.3% |
| Contineum Therapeutics, Inc.(CTNM) | Common Stock | 21217B100 | $8.9M | 542,628 | 5.5% |
| Crispr Therapeutics AG(CRSP) | Common Shares | H17182108 | $8.1M | 148,831 | 5.0% |
| Skye Bioscience, Inc.(SKYE) | Common Stock | 83086J200 | $1.4M | 2,007,704 | 0.9% |
| Tempest Therapeutics, Inc.(OVASUSD) | Common Stock | 87978U108 | $299.4K | 269,772 | 0.2% |